Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-31

Clinical Trial Update: Use of Warfarin After the First Trimester in Pregnant Women With APS [Phase 4]

View source ↗

Summary

Phase 4 trial updating use of warfarin after the first trimester in pregnant women with antiphospholipid syndrome and recurrent miscarriage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: Mohamed Sayed Abdelhafez | Conditions: Recurrent Miscarriage, Antiphospholipid Syndrome | Phase 4 | Status: UNKNOWN